KRAS and adenocarcinoma: The negative prognostic effect of KRAS mutations could also not be confirmed in other studies analysing bigger groups of patients with equally balanced adenocarcinoma vs squamous cell carcinomas (Moldvay et al, 2000; Schiller et al, 2001; Tsao et al, 2007).